SEATTLE, WA, March 29, 2013 /CNW/ - Oncothyreon Inc. (Nasdaq: ONTY) announced today that Robert Kirkman, M.D., President and Chief Executive Officer, will present at the 20th Annual Future Leaders in the Biotech Industry Conference, presented by BioCentury and Thomson Reuters, in New York on Friday, April 5, 2013 at 10:30 a.m. Eastern time.
A live and archived webcast of the presentation will be accessible by visiting the Oncothyreon website www.oncothyreon.com under the "News & Events" section.
Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit www.oncothyreon.com.
SOURCE: Oncothyreon Inc.
For further information:
Investor and Media Relations Contact: